The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

BACKGROUND: Fractional exhaled nitric oxide (FENO) has been shown to be a marker of airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary disease (COPD). In this study, we assessed the FENO level in patients with acute exacerbations of COPD (AECOPD) and analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Aiyuan, Zhou, Zijing, Deng, Dingding, Zhao, Yiyang, Duan, Jiaxi, Cheng, Wei, Liu, Cong, Chen, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522317/
https://www.ncbi.nlm.nih.gov/pubmed/33061343
http://dx.doi.org/10.2147/COPD.S263673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522317/
https://www.ncbi.nlm.nih.gov/pubmed/33061343
http://dx.doi.org/10.2147/COPD.S263673

Ejemplares similares